Therefore, we conclude that, at least in mice, chronic NSAID administration (in the setting of NSAID-induced enteropathy) causes a state of functional GLP-1 deficiency that is associated with hepatic insulin resistance and is reversible after replacement with a GLP-1 receptor agonist. The gene discussed is GLP1R; the disease is Insulin resistance.